copy from Ihub;
Shares of the company (NASDAQ:CELG) were
copy from Ihub;
Shares of the company (NASDAQ:CELG) were still down slightly at midday.
As widely expected, the company released preliminary revenue and financial guidance, maintaining its 2020 revenue target of exceeding $21 billion.
Preliminary total product sales for 2016 are expected to reach nearly $11.2 billion, a 22 percent growth year over year. Sales of Revlimid (lenalidomide) totaled nearly $7 billion, a 20 percent jump over 2015 sales, while Pomalyst (pomalidomide) sales reached $1.3 billion, a 33 percent jump over last year. Sales of Abraxane (nab-paclitaxel) reached nearly $1 billion – $973 million – and sales of Otezla – despite being only in its second year on the market, noted CEO Mark Alles – topping $1 billion and growing by 116 percent over 2015 sales.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...
Continue Reading
Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...
Continue Reading
Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...
Continue Reading
Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...
Continue Reading
The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...
Continue Reading
A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...
Continue Reading
Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...
Continue Reading
RxWellness Spine & Health Continues to Impress Well, not many companies can boast about snagging a spot on the Inc. 5000 list four years in a row, but here we are with RxWellness Spine & Health doing just that. Sitting pretty at No. 1,230 nationally—and that's no small feat—these folks are making waves in the healthcare industry. Securing the No. 135 spot in...
Continue Reading
Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...
Continue Reading
Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...
Continue Reading
Top 5 Most Recently Viewed Articles
BridgeBio Pharma Under NAD Review In a recent development involving regulatory scrutiny, BridgeBio Pharma Inc. is facing a potential referral to governmental authorities. This follows a challenge posed by Pfizer, Inc. regarding BridgeBio’s advertising practices related to its product, Attruby. The National Advertising Division (NAD) of BBB National Programs has...
Continue Reading
Evaluating Microsoft's Position in the Software Industry In today's competitive business landscape, analyzing companies meticulously is essential for both investors and industry followers. This article seeks to provide a detailed comparison of Microsoft (NASDAQ: MSFT) alongside its key competitors within the software sector. By scrutinizing vital financial indicators,...
Continue Reading
Fast Moves in Manufacturing Equipment Liquidation Alright, gather 'round. Tiger Commercial & Industrial (C&I) recently wrapped up a speedy sale of high-precision fabrication and assembly machinery from two U.S. plants. We're talking about substantial inventory here, including equipment from once-bustling facilities in Alpharetta, Georgia, and Dallas, Texas. This wasn't...
Continue Reading
Approval for Eco-Friendly LNG Carrier Conversion Hanwha Power Systems is making waves in the maritime industry with its groundbreaking Approval in Principle (AiP) from the American Bureau of Shipping (ABS) for retrofitting 174K LNG carriers to operate on ammonia fuel. This pivotal achievement highlights the incredible potential of converting existing vessels into more...
Continue Reading
Vesalio's New Clinical Study for pVasc™ Thrombectomy System Vesalio is embarking on an exciting clinical study initiative designed to gather real-world data for their groundbreaking pVasc™ Thrombectomy System. This comprehensive study aims to redefine treatment options for patients grappling with peripheral vascular disease and improve clinical outcomes significantly....
Continue Reading